Skip to content

Public FDA record

Z-0966-2017: Ceres-C Standalone Cervical Interbody The product is a stand-alone anterior cervical interbody fusion de

Recall record Z-0966-2017 for Amendia, Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0966-2017
Company in FDA record
Amendia, Inc
FDA classification date
Jan 9, 2017
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Absent tantalum market pin.

Source facts

Action
The firm, Amendia, contacted the consignee and issued a Return Material Authorization for the affected product on 8/18/2016. Please contact Regulatory and Quality Consultant for Amendia at 404-610-7215 or by email to bbrosseau@securebme.com with any questions or concerns regarding this recall notification.
Initiated
2016-11-22
Root cause
Process control
Terminated
2017-02-28
Distribution
US Distribution to GA only.
Recall number
Z-0966-2017
Recall status
Terminated
CDRH record ID
151460
FDA classified
2017-01-09
Recall event number
75857

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗